Lv4
610 积分 2025-11-15 加入
Efficacy and safety of obinutuzumab β in patients with active systemic lupus erythematosus: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
9天前
已关闭
Efficacy and safety of obinutuzumab β in patients with active systemic lupus erythematosus: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
9天前
已关闭
CAR T cells for autoimmune diseases: 2026 update of the EBMT–ISCT–JACIE practice harmonisation and consensus recommendations
1个月前
已完结
Low-dose belimumab reduced risk of flares in patients with systemic lupus erythematosus: a multicentre, randomised, double-blind, placebo-controlled trial
3个月前
已完结
泰它西普联合小剂量吗替麦考酚酯对中重度系统性红斑狼疮的疗效观察
3个月前
已完结
Comparative effectiveness and predictors of SRI-4 and LLDAS attainment in active systemic lupus erythematosus: a real-world study of telitacicept versus belimumab
3个月前
已完结
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
3个月前
已完结
Attainment of remission and low disease activity after treatment with belimumab in patients with systemic lupus erythematosus: a post-hoc analysis of pooled data from five randomised clinical trials
6个月前
已完结
Mortality and prognostic factors among inpatients with systemic lupus erythematosus in China: A 20-year retrospective study
6个月前
已完结
Mortality in patients with systemic lupus erythematosus: A meta-analysis of overall and cause-specific effects
6个月前
已完结